343 related articles for article (PubMed ID: 26733347)
1. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
2. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
3. Urinary heme oxygenase-1 as a sensitive indicator of tubulointerstitial inflammatory damage in various renal diseases.
Yokoyama T; Shimizu M; Ohta K; Yuno T; Okajima M; Wada T; Toma T; Koizumi S; Yachie A
Am J Nephrol; 2011; 33(5):414-20. PubMed ID: 21502755
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.
Sun AL; Deng JT; Guan GJ; Chen SH; Liu YT; Cheng J; Li ZW; Zhuang XH; Sun FD; Deng HP
Diab Vasc Dis Res; 2012 Oct; 9(4):301-8. PubMed ID: 22388283
[TBL] [Abstract][Full Text] [Related]
5. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of random albumin creatinine ratio for detection of micro and macro-albuminuria in type 2 diabetes mellitus.
Hasanato RM
Saudi Med J; 2016 Mar; 37(3):268-73. PubMed ID: 26905348
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
10. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy.
Yagame M; Suzuki D; Jinde K; Yano N; Naka R; Abe Y; Nomoto Y; Sakai H; Suzuki H; Ohashi Y
Intern Med; 1995 Jun; 34(6):463-8. PubMed ID: 7549125
[TBL] [Abstract][Full Text] [Related]
11. Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstruction.
Li Z; Liu X; Liu S; Gu C; Tian F; Wen J
Biomarkers; 2012 Aug; 17(5):471-6. PubMed ID: 22630328
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
[TBL] [Abstract][Full Text] [Related]
13. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy.
Masulli M; Mancini M; Liuzzi R; Daniele S; Mainenti PP; Vergara E; Genovese S; Salvatore M; Vaccaro O
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):358-64. PubMed ID: 18805683
[TBL] [Abstract][Full Text] [Related]
14. Assessing albuminuria in spot morning samples from diabetic patients.
Sampaio E; Delfino VD
Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1482-8. PubMed ID: 19197457
[TBL] [Abstract][Full Text] [Related]
15. Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore.
Hong CY; Hughes K; Chia KS; Ng V; Ling SL
Diabetes Care; 2003 Feb; 26(2):338-42. PubMed ID: 12547859
[TBL] [Abstract][Full Text] [Related]
16. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tests for microalbuminuria screening in patients with diabetes.
Incerti J; Zelmanovitz T; Camargo JL; Gross JL; de Azevedo MJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2402-7. PubMed ID: 16105865
[TBL] [Abstract][Full Text] [Related]
18. [Albumin-to-creatinine ratio as a diagnostic tool for type 2 diabetic nephropathy].
Mundet Tudurí X; Martínez Carmona S; Espinosa González N; López Rodway C; Carrera Font T; Romea Lecumberri S; Gimbert Ràfols R; Martí Montesa J
Med Clin (Barc); 2001 May; 116(19):732-3. PubMed ID: 11412693
[TBL] [Abstract][Full Text] [Related]
19. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay.
Comper WD; Osicka TM; Clark M; MacIsaac RJ; Jerums G
Kidney Int; 2004 May; 65(5):1850-5. PubMed ID: 15086926
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.
Satirapoj B; Siritaweesuk N; Supasyndh O
Clin Kidney J; 2014 Aug; 7(4):354-60. PubMed ID: 25852909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
